Computer Vision News - December 2021

38 Medical Imaging Application (PET) . Amyloid plaque deposition is a very strong risk indicator for Alzheimer’s. If you do not have any of those plaques in the brain, you have no risk of Alzheimer’s in the next 10 years. If you do, then it should be monitored because those plaques are always there when Alzheimer’s develops, and they are there 10 to 20 years before the first cognitive symptoms . Currently, PET scans are very expensive and require large devices that take up a lot of space. A few years ago, Professor Alfred Buck from University Hospital Zurich approached Positrigo about the need for a smaller, simpler, more affordable system. He suggested they work on a solution. “ PET imaging is the gold standard for the Jannis Fischer is co-founder and CEO of Positrigo, a MedTech startup that has been developing an exciting new technology for the early diagnosis of Alzheimer’s disease. He tells us more about this revolutionary system that is set to take the medical imaging industry by storm. Alzheimer’s disease affects millions of people worldwide and costs the world hundreds of billions of dollars each year. Work on medication continues, with several new treatments on the horizon, but early diagnosis is key to ensure medication is given at the first opportunity to ensure the maximum effect. The best way to diagnose Alzheimer’s is via a brain scan using a technology called Positron Emission Tomography A rendering of how the device will look like in the future, from next year on.